Artificial Intelligence With Determination of Central Venous Catheter Line Associated Infection Risk
NCT ID: NCT05914571
Last Updated: 2023-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2023-07-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\]it aims to answer are:
* Can the risk of CVC-related infection be determined in adult intensive care patients using artificial intelligence?
* To what degree of accuracy can the risk of CVC-associated infection be determined in adult intensive care patients using artificial intelligence?
* What are the nursing practices that can reduce the risk of CVC-related infections?
Methodology to develop an artificial intelligence-based CVC-associated infection risk level determination algorithm, retrospective using data from Electronic Health Records (EHR) patient data and manual patient files between January 2018 and December 2022 to create the algorithm and test the model accuracy, and the development stages of the model After the completion of the model, up-to-date data were collected for the use of the model and it was planned to be done prospectively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preventing Central Catheter-Associated Bloodstream Infections
NCT04920877
Complications Associated With Central Venous Access in the NSICU: PICC vs CVC
NCT02314520
Prevention of Phlebitis, Infiltration and Extravasation With Infusion Monitoring System
NCT07046624
Daily Ultrasound-screening for CVC-related Thrombosis
NCT03327376
A Trial to Study the Influence of Ultrasound Guidance on the Complications of Central Catheter
NCT01154465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18,
* CVC inserted,
* No existing infection before hospitalization, patient data will be included in the dataset for designing and training the artificial intelligence model.
Exclusion Criteria
* Those receiving immunosuppressive therapy,
* Those with multiple organ failure,
* Patients undergoing organ transplantation,
* Patients with a diagnosis of chronic kidney failure, will not be included in the dataset.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OTCELEBİ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.